US Stock MarketDetailed Quotes

MDCX Medicus Pharma

Watchlist
  • 2.660
  • -0.140-5.00%
Trading Dec 12 11:15 ET
31.43MMarket Cap-1.29P/E (TTM)

Medicus Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,964.91%-3.07M
-616.90%-2.74M
-391.30%-1.18M
-293.36%-4.16M
-926.35%-3.39M
15.41%-148.58K
-63.92%-381.52K
24.80%-239.56K
27.00%-1.06M
-330.16K
Net income from continuing operations
0.15%-2.96M
-745.19%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
2.08%-488.67K
-0.12%-483.92K
17.66%-1.69M
---322.21K
Depreciation and amortization
--26.32K
--26.04K
--26.04K
----
----
--0
--0
--0
----
----
Other non cash items
-99.33%8.98K
-62.12%88.26K
-88.93%9.01K
131.17%1.65M
--0
1,047.54%1.34M
-2.96%232.98K
-62.23%81.39K
16.30%713.97K
--141.95K
Change In working capital
-109.74%-144.09K
711.91%769.95K
212.75%509.72K
1,153.22%828.74K
-358.61%-687.42K
1,445.12%1.48M
-570.09%-125.83K
2,940.31%162.98K
-1,081.84%-78.69K
---149.89K
-Change in prepaid assets
-1,014.59%-69.1K
--44.81K
753.07%61.64K
-958.13%-158.72K
-1,056.67%-173.5K
--7.56K
--0
--7.23K
---15K
---15K
-Change in payables and accrued expense
-105.10%-74.99K
676.29%725.14K
187.69%448.08K
1,650.49%987.46K
-280.98%-513.92K
1,437.23%1.47M
-570.09%-125.83K
2,814.38%155.75K
-856.55%-63.69K
---134.89K
Cash from discontinued investing activities
Operating cash flow
-1,964.91%-3.07M
-616.90%-2.74M
-391.30%-1.18M
-293.36%-4.16M
-926.35%-3.39M
15.41%-148.58K
-37.36%-381.52K
12.43%-239.56K
27.00%-1.06M
---330.16K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-100.69%-35.04K
350.15%5.61M
0
10,119.90%5.11M
41.24%1.25M
591.33K
Net issuance payments of debt
---35.04K
----
----
-59.88%500K
--0
--0
----
----
41.24%1.25M
--591.33K
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Cash dividends paid
--0
----
----
----
----
--0
----
----
----
----
Net other financing activities
----
----
----
--5.11M
--0
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-100.69%-35.04K
----
----
350.15%5.61M
--0
10,119.90%5.11M
----
----
41.24%1.25M
--591.33K
Net cash flow
Beginning cash position
5,637.21%8.41M
1,830.54%542.41K
542.38%1.72M
240.90%267.65K
78,726.31%5.11M
10.94%146.57K
-93.15%28.1K
240.90%267.65K
-87.81%78.51K
--6.48K
Current changes in cash
-162.54%-3.1M
6,539.93%7.87M
-391.30%-1.18M
667.53%1.45M
-1,397.46%-3.39M
4,049.01%4.96M
142.66%118.48K
-172.30%-239.56K
133.44%189.14K
--261.17K
End cash Position
3.88%5.31M
5,637.21%8.41M
1,830.54%542.41K
542.38%1.72M
542.38%1.72M
78,726.31%5.11M
10.94%146.57K
-93.15%28.1K
240.90%267.65K
--267.65K
Free cash flow
-1,964.91%-3.07M
-616.90%-2.74M
-391.30%-1.18M
-293.36%-4.16M
-926.35%-3.39M
15.41%-148.58K
-37.36%-381.52K
12.43%-239.56K
27.00%-1.06M
---330.16K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unaudited
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,964.91%-3.07M-616.90%-2.74M-391.30%-1.18M-293.36%-4.16M-926.35%-3.39M15.41%-148.58K-63.92%-381.52K24.80%-239.56K27.00%-1.06M-330.16K
Net income from continuing operations 0.15%-2.96M-745.19%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M2.08%-488.67K-0.12%-483.92K17.66%-1.69M---322.21K
Depreciation and amortization --26.32K--26.04K--26.04K----------0--0--0--------
Other non cash items -99.33%8.98K-62.12%88.26K-88.93%9.01K131.17%1.65M--01,047.54%1.34M-2.96%232.98K-62.23%81.39K16.30%713.97K--141.95K
Change In working capital -109.74%-144.09K711.91%769.95K212.75%509.72K1,153.22%828.74K-358.61%-687.42K1,445.12%1.48M-570.09%-125.83K2,940.31%162.98K-1,081.84%-78.69K---149.89K
-Change in prepaid assets -1,014.59%-69.1K--44.81K753.07%61.64K-958.13%-158.72K-1,056.67%-173.5K--7.56K--0--7.23K---15K---15K
-Change in payables and accrued expense -105.10%-74.99K676.29%725.14K187.69%448.08K1,650.49%987.46K-280.98%-513.92K1,437.23%1.47M-570.09%-125.83K2,814.38%155.75K-856.55%-63.69K---134.89K
Cash from discontinued investing activities
Operating cash flow -1,964.91%-3.07M-616.90%-2.74M-391.30%-1.18M-293.36%-4.16M-926.35%-3.39M15.41%-148.58K-37.36%-381.52K12.43%-239.56K27.00%-1.06M---330.16K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -100.69%-35.04K350.15%5.61M010,119.90%5.11M41.24%1.25M591.33K
Net issuance payments of debt ---35.04K---------59.88%500K--0--0--------41.24%1.25M--591.33K
Net common stock issuance --0------------------0----------------
Cash dividends paid --0------------------0----------------
Net other financing activities --------------5.11M--0--------------------
Cash from discontinued financing activities
Financing cash flow -100.69%-35.04K--------350.15%5.61M--010,119.90%5.11M--------41.24%1.25M--591.33K
Net cash flow
Beginning cash position 5,637.21%8.41M1,830.54%542.41K542.38%1.72M240.90%267.65K78,726.31%5.11M10.94%146.57K-93.15%28.1K240.90%267.65K-87.81%78.51K--6.48K
Current changes in cash -162.54%-3.1M6,539.93%7.87M-391.30%-1.18M667.53%1.45M-1,397.46%-3.39M4,049.01%4.96M142.66%118.48K-172.30%-239.56K133.44%189.14K--261.17K
End cash Position 3.88%5.31M5,637.21%8.41M1,830.54%542.41K542.38%1.72M542.38%1.72M78,726.31%5.11M10.94%146.57K-93.15%28.1K240.90%267.65K--267.65K
Free cash flow -1,964.91%-3.07M-616.90%-2.74M-391.30%-1.18M-293.36%-4.16M-926.35%-3.39M15.41%-148.58K-37.36%-381.52K12.43%-239.56K27.00%-1.06M---330.16K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unaudited------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data